Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9604922
APP PUB NO 20150239829A1
SERIAL NO

14630248

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides compounds and pharmaceutical compositions for treating neurological diseases such as multiple sclerosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALKERMES PHARMA IRELAND LIMITED1 BURLINGTON ROAD CONNAUGHT HOUSE DUBLIN 4

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hencken, Christopher P Boston, US 28 210
Wynn, Thomas Andrew Lexington, US 38 274

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 28, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00